Google's Isomorphic Labs Seeks Over $2 Billion

Isomorphic Labs, an AI-driven drug discovery venture originating from Google DeepMind, is reportedly nearing the completion of a significant funding round. The company is in advanced talks to secure over $2 billion, signaling strong investor confidence in its innovative approach to pharmaceutical research. This substantial capital infusion is expected to accelerate Isomorphic Labs' mission to leverage artificial intelligence for faster and more efficient drug development, potentially revolutionizing the healthcare industry.